Nymox Pharmaceutical Corp SEC filings NYMXF

Nymox Pharmaceutical Corp has 408 filings in SEC EDGAR's recent list, going back to Aug 8, 1996. Its latest annual report, Form 20-F, was filed on Sep 14, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Aug 31, 2026. The company's fiscal year ends on December 31.

Nymox Pharmaceutical Corp SEC filings
Form Description Filed Period
4/A Primary document Jun 26, 2023 Apr 25, 2023
4/A Primary document May 18, 2023 Apr 25, 2023
4 Insider transaction May 6, 2022 May 2, 2022
4 Insider transaction Apr 27, 2021 Apr 21, 2021
4 Insider transaction Jul 12, 2019 Jul 10, 2019
4 Insider transaction Jul 10, 2019 Jul 10, 2019
4 Insider transaction Jul 9, 2019 Jul 5, 2019
4 Insider transaction Jul 3, 2019 Jul 2, 2019
4 Insider transaction Jul 2, 2019 Jul 1, 2019
4 Insider transaction Jul 1, 2019 Jun 28, 2019
4 Insider transaction Jun 28, 2019 Jun 27, 2019
4 Insider transaction Jun 27, 2019 Jun 26, 2019
4 Insider transaction Jun 26, 2019 Jun 25, 2019
4 Insider transaction Jun 21, 2019 Jun 20, 2019
4 Insider transaction Jun 20, 2019 Jun 19, 2019
4 Insider transaction Jun 19, 2019 Jun 18, 2019
4 Insider transaction Jun 18, 2019 Jun 13, 2019
4 Insider transaction Jun 12, 2019 Jun 11, 2019
4 Insider transaction Jun 12, 2019 Jun 10, 2019
4 Insider transaction Jun 7, 2019 Jun 6, 2019
4 Insider transaction Jun 6, 2019 Jun 5, 2019
4 Insider transaction Jun 4, 2019 Jun 3, 2019
4 Insider transaction Jun 4, 2019 May 31, 2019
4 Insider transaction May 31, 2019 May 30, 2019
4 Insider transaction May 30, 2019 May 28, 2019
4 Insider transaction May 28, 2019 May 24, 2019
4 Insider transaction May 28, 2019 May 23, 2019
4 Insider transaction Jan 3, 2019 Dec 21, 2018
4 Insider transaction Jan 3, 2019 Dec 19, 2018
4 Insider transaction Dec 14, 2018 Dec 13, 2018
4 Insider transaction Dec 13, 2018 Dec 12, 2018
4 Insider transaction Dec 12, 2018 Dec 11, 2018
4 Insider transaction Dec 11, 2018 Dec 10, 2018
4 Insider transaction Dec 10, 2018 Dec 7, 2018
4 Insider transaction Dec 7, 2018 Dec 6, 2018
4 Insider transaction Dec 6, 2018 Dec 4, 2018
4 Insider transaction Dec 3, 2018 Nov 30, 2018
4 Insider transaction Nov 30, 2018 Nov 29, 2018
4 Insider transaction Nov 28, 2018 Nov 27, 2018
4 Insider transaction Nov 21, 2018 Nov 20, 2018
4 Insider transaction Nov 21, 2018 Nov 19, 2018
4 Insider transaction Nov 21, 2018 Nov 16, 2018
4 Insider transaction Nov 15, 2018 Nov 13, 2018
4 Insider transaction Nov 13, 2018 Nov 9, 2018
4 Insider transaction Nov 9, 2018 Nov 7, 2018
4 Insider transaction Nov 6, 2018 Oct 26, 2018
4 Insider transaction Nov 6, 2018 Oct 29, 2018
4 Insider transaction Nov 6, 2018 Oct 28, 2018
4 Insider transaction Nov 6, 2018 Nov 2, 2018
4 Insider transaction Nov 2, 2018 Nov 1, 2018
4 Insider transaction Nov 1, 2018 Oct 31, 2018
4 Insider transaction Nov 1, 2018 Oct 30, 2018
4 Insider transaction Oct 26, 2018 Oct 25, 2018
4 Insider transaction Oct 25, 2018 Oct 22, 2018
4 Insider transaction Oct 25, 2018 Oct 22, 2018
4 Insider transaction Mar 27, 2018 Mar 26, 2018
4 Insider transaction Mar 22, 2018 Mar 20, 2018
4 Insider transaction Mar 16, 2018 Mar 15, 2018
4 Insider transaction Mar 12, 2018 Mar 9, 2018
4 Insider transaction Feb 23, 2018 Feb 21, 2018
4 Insider transaction Feb 20, 2018 Feb 16, 2018
4 Insider transaction Feb 13, 2018 Feb 12, 2018
4 Insider transaction Feb 12, 2018 Feb 9, 2018
4 Insider transaction Feb 9, 2018 Feb 8, 2018
4 Insider transaction Feb 6, 2018 Feb 2, 2018
4 Insider transaction Jan 22, 2018 Jan 18, 2018
4 Insider transaction Aug 4, 2017 Aug 2, 2017
4 Insider transaction Aug 1, 2017 Jul 28, 2017
4 Insider transaction Jul 7, 2017 Jul 5, 2017
4 Insider transaction Jun 29, 2017 Jun 27, 2017
4 Insider transaction Jun 26, 2017 Jun 22, 2017
4 Insider transaction Jun 21, 2017 Jun 19, 2017
4 Insider transaction May 31, 2017 May 26, 2017
4 Insider transaction Mar 29, 2017 Mar 8, 2017
3 Initial insider ownership Aug 23, 2016 Aug 10, 2016
4 Insider transaction Aug 12, 2016 Aug 10, 2016
4 Insider transaction Aug 5, 2016 Aug 1, 2016
4 Insider transaction Jul 29, 2016 Jul 25, 2016
4 Insider transaction Jul 22, 2016 Jul 18, 2016
4 Insider transaction Jul 7, 2016 Jul 5, 2016
4 Insider transaction Jul 1, 2016 Jun 27, 2016
4 Insider transaction Jun 24, 2016 Jun 22, 2016
4 Insider transaction May 13, 2016 May 10, 2016
4 Insider transaction May 6, 2016 May 2, 2016
4 Insider transaction Apr 29, 2016 Apr 28, 2016
4 Insider transaction Apr 15, 2016 Apr 11, 2016
4 Insider transaction Apr 1, 2016 Mar 28, 2016
4 Insider transaction Mar 25, 2016 Mar 21, 2016
4 Insider transaction Jan 13, 2016 Jan 11, 2016
4 Insider transaction Jan 8, 2016 Jan 4, 2016
4 Insider transaction Dec 30, 2015 Dec 28, 2015
4 Insider transaction Dec 24, 2015 Dec 21, 2015
4 Insider transaction Dec 18, 2015 Dec 14, 2015
4 Insider transaction Dec 11, 2015 Dec 7, 2015
4 Insider transaction Dec 4, 2015 Nov 30, 2015
4 Insider transaction Sep 8, 2015 Aug 21, 2015
SC 13D Ownership over 5% (active) Aug 27, 2015 —
SC 13G/A Amended ownership over 5% (passive) Feb 11, 2014 —
SC 13G/A Amended ownership over 5% (passive) Mar 6, 2013 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2013 —
SC 13G/A Amended ownership over 5% (passive) Feb 15, 2011 —
SC 13G/A Amended ownership over 5% (passive) Feb 15, 2011 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2011 —
SC 13G Ownership over 5% (passive) Mar 31, 2010 —
SC 13G/A Amended ownership over 5% (passive) Feb 16, 2010 —
SC 13G/A Amended ownership over 5% (passive) Mar 20, 2009 —
SC 13G/A Amended ownership over 5% (passive) Feb 18, 2009 —
SC 13G Ownership over 5% (passive) Nov 20, 2008 —
SC 13G Ownership over 5% (passive) Mar 14, 2008 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2008 —
SC 13G Ownership over 5% (passive) Mar 30, 2006 —
SC 13D Ownership over 5% (active) Jan 30, 2004 —
SC 13G Ownership over 5% (passive) Aug 26, 2002 —

Showing 113 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
In Vitro & In Vivo Diagnostic Substances (SIC 2835)
Listed as
NYMXF (OTC)
Fiscal year ends
December 31
Headquarters
Quebec Canada, Quebec, Canada
SEC filer status
Accelerated filer
SEC CIK
1018735

Other In Vitro & In Vivo Diagnostic Substances companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.